Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation With a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients

drug protocol number
IN 0901 INT
drug sponsor
Leo
drug study
Innohep (Tinzaparin) VS. Warfarin
drug trial site
NGHA-R
drug status
Completed
drug phase